Description : During hemdialysis process I. blood drained from a conveniend artery and anticoagulant is added (heparin). II. Removal of nitrogenous waste from blood
Last Answer : During hemdialysis process I. blood drained from a conveniend artery and anticoagulant is added (heparin). II. ... D. `I rarr IV rarr II rarr III`
Description : Which of the following is an anticoagulant and checks blood coagulation in blood vessels?
Last Answer : Which of the following is an anticoagulant and checks blood coagulation in blood vessels? A. Prothrombin B. Globulin C. Thromboplatin D. Heparin
Description : Which type of white blood cells are concerned with the release of histamine and the natural anticoagulant heparin ?
Last Answer : Which type of white blood cells are concerned with the release of histamine and the natural ... Eosinophils B. Monocytes C. Neutrophils D. Basophils
Description : Which one is the common anticoagulant used for preserving blood?
Last Answer : Which one is the common anticoagulant used for preserving blood? A. NaCl B. Sodium oxalate C. KCl D. Thromboplastin
Description : Which is the anticoagulant substance in blood? (1) Fibrinogen (2) Heparin (3) Thrombin (4) Globin
Last Answer : (2) Heparin Explanation: Heparin, a highly sulfated glycosaminoglycan, is widely used as an inject able anticoagulant, and has the highest negative charge density of any known ... because blood anti-coagulation is achieved mostly by heparin sulfate proteoglyeans derived from endothelial cells.
Description : Which type of white blood cells are concerned with the release of histamine and the natural anticoagulant heparin? (a) Eosinophils (b) Monocytes (c) Neutrophils (d) Basophils
Last Answer : d) Basophils
Description : In blood, which anticoagulant substance found
Last Answer : Heparin
Description : The following is true of heparin except: A. Sudden stoppage of continuous heparin therapy causes rebound increase in blood coagulability B. High doses of heparin inhibit platelet aggregation ... active circulating anticoagulant D. Heparin clears lipemic plasma in vivo but not in vitro
Last Answer : C. Heparin is the physiologically active circulating anticoagulant
Description : The following statements are true of oral anticoagulants except: A. They interfere with an early step in the synthesis of clotting factors B. Irrespective of the dose administered, their ... dose is adjusted by repeated measurement of prothrombin time D. They are contraindicated during pregnancy
Last Answer : A. They interfere with an early step in the synthesis of clotting factors
Description : Assertion: Heparin is an anticoagulant found in mammals. Reason: Heparin prevents the conversion of prothrombin to thrombin
Last Answer : Assertion: Heparin is an anticoagulant found in mammals. Reason: Heparin prevents the conversion of ... . If both Assertion & Reason are false.
Description : An anticoagulant is
Last Answer : An anticoagulant is A. Heparin B. Hirudin C. EDTA D. All the above
Description : As thrombin generation proceeds, the body has natural anticoagulant systems opposing further thrombus formation. Natural anticoagulants include: a. Tissue plasminogen activator (TPA) b. Antithrombin III c. Activated protein C d. Heparin cofactor II
Last Answer : Answer: b, c, d Just as thrombin generation is the key to coagulation, antithrombin III is the most central anticoagulant proteins. This glycoprotein binds to thrombin, preventing its removal of ... in the body. Therefore, TPA is part of the fibrinolytic system rather than a natural anticoagulant
Description : The standard management oral anticoagulant therapy for chronic treatment of venous thromboembolism is with the drug warfarin. Which of the following statement(s) is/are true concerning the administration ... warfarin be continued for at least one year after initial episode of deep venous thrombosis
Last Answer : Answer: a, b Warfarin interferes with the vitamin K dependent clotting factors II, VII, IX and X, protein C, and protein S. An important complication of warfarin is skin ... the benefit from anticoagulant therapy and thus is the basis for discontinuing warfarin administration at this time
Description : A patient on oral anticoagulant therapy is commenced on sulfamethoxazoletrimethoprim, double-strength twice daily. One may expect to see the international normalized ratio (a) Increase (b) Decrease (c) Remain unchanged
Last Answer : Ans: A
Description : A patient to be commenced on oral anticoagulant therapy for DVT would be treated with (a) Oral anticoagulant therapy with warfarin for a goal intenational normalized ration (INR) of 2-3 (b) Oral anticoagulant therapy ... of 2.5-3.5 (c) Oral anticoagulant therapy with aspirin for a goal INR of 2-3
Description : Name the anticoagulant present in leech?
Last Answer : Hirudin
Description : Anticoagulant medication is indicated in: A. Immobilized elederly patients B. Buerger’s disease C. Stroke due to cerebral thrombosis D. All of the above
Last Answer : A. Immobilized elederly patients
Description : You are treating a patient of deep vein thrombosis with warfarin. What value of International normalized ratio (INR) will you attempt by adjusting dose of the anticoagulant for an adequate therapeutic effect: A. 1.2 – 1.5 B. 1.3 – 1.7 C. 1.5 – 2.0 D. 2.0 – 3.0
Last Answer : D. 2.0 – 3.0
Description : Why should care be taken when prescribing warfarin and amiodarone in combination? A. Amiodarone and warfarin both have an anticoagulant effect. B. Amiodarone may reverse the anticoagulant ... anticoagulant effect of warfarin. D. Warfarin may reverse the antiarrhythmic effect of amiodarone.
Last Answer : C. Amiodarone may increase the anticoagulant effect of warfarin.